Acuta Capital Partners as of March 31, 2026
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 26 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ideaya Biosciences Call Call Option (IDYA) | 53.8 | $162M | 49k | 3332.00 | |
| Praxis Precision Medicines I Com New (PRAX) | 9.1 | $27M | 85k | 322.19 | |
| Terns Pharmaceuticals (TERN) | 8.7 | $26M | 496k | 52.72 | |
| Aadi Bioscience (WHWK) | 3.9 | $12M | 3.4M | 3.45 | |
| Tango Therapeutics (TNGX) | 3.1 | $9.2M | 442k | 20.92 | |
| Bright Minds Biosciences Com New (DRUG) | 2.7 | $8.2M | 112k | 72.97 | |
| Sutro Biopharma (STRO) | 2.2 | $6.7M | 269k | 24.91 | |
| Erasca (ERAS) | 1.9 | $5.7M | 355k | 16.18 | |
| Surrozen Com New (SRZN) | 1.7 | $5.0M | 173k | 29.13 | |
| Ocular Therapeutix (OCUL) | 1.7 | $5.0M | 592k | 8.47 | |
| Compass Therapeutics (CMPX) | 1.5 | $4.5M | 849k | 5.29 | |
| Minerva Neurosciences Com New (NERV) | 1.4 | $4.3M | 710k | 6.03 | |
| Moonlake Immunotherapeutics Class Ord A (MLTX) | 1.2 | $3.6M | 192k | 18.64 | |
| Argen Se - Sponsored Adr (ARGX) | 1.1 | $3.4M | 4.7k | 730.25 | |
| Oculis Holding Ordinary Shares (OCS) | 0.9 | $2.6M | 98k | 26.59 | |
| Revolution Medicines (RVMD) | 0.8 | $2.5M | 26k | 97.25 | |
| 4d Molecular Therapeutics In | 0.7 | $2.3M | 242k | 9.31 | |
| Amylyx Pharmaceuticals (AMLX) | 0.7 | $2.1M | 151k | 13.90 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.7 | $2.0M | 440k | 4.47 | |
| Design Therapeutics (DSGN) | 0.5 | $1.6M | 146k | 10.64 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $1.3M | 2.2k | 592.98 | |
| Entrada Therapeutics (TRDA) | 0.4 | $1.1M | 89k | 12.62 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $908k | 61k | 14.93 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 0.2 | $713k | 29k | 24.66 | |
| Maze Therapeatics (MAZE) | 0.2 | $577k | 19k | 29.85 | |
| Unicycive Therapeutics (UNCY) | 0.1 | $381k | 58k | 6.58 |
